SurModics, Inc.
SRDX
$27.09
$0.331.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.14% | -9.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.14% | -9.95% | |||
| Cost of Revenue | -1.03% | 181.90% | |||
| Gross Profit | -12.30% | -74.52% | |||
| SG&A Expenses | -2.56% | 18.34% | |||
| Depreciation & Amortization | -1.16% | -2.49% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.69% | -0.12% | |||
| Operating Income | -734.25% | -105.86% | |||
| Income Before Tax | -59.04% | -158.93% | |||
| Income Tax Expenses | -25.46% | -69.42% | |||
| Earnings from Continuing Operations | -42.67% | -5.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -42.67% | -5.86% | |||
| EBIT | -734.25% | -105.86% | |||
| EBITDA | -66.93% | -63.61% | |||
| EPS Basic | -42.17% | -5.55% | |||
| Normalized Basic EPS | -237.46% | -125.07% | |||
| EPS Diluted | -40.31% | -4.08% | |||
| Normalized Diluted EPS | -237.46% | -125.07% | |||
| Average Basic Shares Outstanding | 0.33% | 0.30% | |||
| Average Diluted Shares Outstanding | 0.33% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||